MagnetOs Putty
Lumbar Interbody Fusion (Degenerative Disc Disease)
CommercialMarketed
Key Facts
Indication
Lumbar Interbody Fusion (Degenerative Disc Disease)
Phase
Commercial
Status
Marketed
Company
About Kuros Biosciences
Kuros Biosciences is a commercial-stage orthobiologics company with a mission to address unmet clinical needs for safer, faster, and more predictable bone healing. Its core technology, MagnetOs, is supported by a robust clinical evidence program called Project Fusion, which includes Level I human clinical data demonstrating superior fusion rates compared to autograft. The company leverages a global commercial footprint and strategic advisory boards of leading surgeons to drive adoption of its products in spinal fusion and other orthopedic procedures.
View full company profile